![Xue Hai Tan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xue Hai Tan
Chief Executive Officer at HD Biosciences Co., Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pei Yuan Lin | M | - |
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | - |
Jing Cai Chen | M | - |
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | 18 years |
Mao Sheng Duan | M | - |
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | - |
Bai Qiu Wang | M | - |
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | 17 years |
Ko Yi Liu | M | 58 |
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bao Zhong Zhang | M | - |
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | - |
Thomas Rutherford | M | 71 |
University of Toledo Medical Center
| 3 years |
Xian Qiang Li | M | 64 |
University of Toledo Medical Center
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 6 | 75.00% |
United States | 2 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Xue Hai Tan
- Personal Network